erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the..
© telegraph media group limited 2018
the financial times and its journalism are subject to a self-regulation regime under the ft editorial code of practice:... april 2011 (16)